@inbook{7edd0f0e4eba425c9b21fd1ec1b23e2a,
title = "Chapter 19 Estrogen in Systemic Lupus Erythematosus: Lessons from the SELENA Study",
abstract = "There is a strong female predominance in SLE, implicating estrogens in the pathogenesis of disease. However, recent studies have shown that exogenous estrogens, given as oral contraceptives or HRT, do not increase the risk of mild or moderate flares in women with SLE. These and other studies provide physicians with new evidence for the rational use of estrogen therapy in women with SLE. {A textbox is presented}.",
author = "Sule, {Sangeeta D.} and Michelle Petri",
year = "2008",
doi = "10.1016/S1571-5078(07)00219-X",
language = "English (US)",
isbn = "9780444531728",
series = "Handbook of Systemic Autoimmune Diseases",
pages = "223--227",
editor = "Sara Walker and Luis Jara",
booktitle = "Endocrine Manifestations of Systemic Autoimmune Diseases",
}